Patent: 8,980,626
✉ Email this page to a colleague
Summary for Patent: 8,980,626
| Title: | Vectors, host cells, and methods of production and uses |
| Abstract: | Antibody expression vectors and plasmids can incorporate various antibody gene portions for transcription of the antibody DNA and expression of the antibody in an appropriate host cell. The expression vectors and plasmids have restriction enzyme sites that facilitate ligation of antibody-encoding DNA into the vectors. The vectors incorporate enhancer and promoter sequences that can be varied to interact with transcription factors in the host cell and thereby control transcription of the antibody-encoding DNA. A kit can incorporate these vectors and plasmids. |
| Inventor(s): | Carton; Jill (Spring House, PA), Lu; Jin (Spring House, PA), Scallon; Bernard (Spring House, PA), Snyder; Linda (Spring House, PA) |
| Assignee: | Janssen Biotech, Inc. (Horsham, PA) |
| Application Number: | 14/163,469 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,980,626
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
